Followers | 261 |
Posts | 19732 |
Boards Moderated | 0 |
Alias Born | 10/03/2004 |
Thursday, June 21, 2012 11:22:56 PM
The biggest problem for the animal/human equivalence model is simply the liver. Although livers are livers whether human or animal, how the liver interacts with a drug has great variation from species to species. A drug that shows low liver toxicity in test animals may actually kill a human liver. Likewise the same for kidneys and other parts of the renal system. So, human tox studies in phase 1, dosing and tolerance, are a critical part of testing whether the anticipated reaction from animal models holds true for humans.
The second major issue is interaction with the immune system. Again, mice and humans may react differently. Immunal responses in humans may be different. A drug may cause an immunal storm in a human that is not or cannot be detected in mice. Even more, immunal reaction can manifest in ways that mice show no signs. After all, mice can't speak to tell lab workers that the drug just gave them crippling migraine-like headaches.
The third, but probably least issue, is genotoxicity. So far there have been no signs in animals, in particular in the human xenografts. But, although I don't think this will happen, if Kevetrin showed signs of genetic damage in humans that was not present in animals, it would not be one of the first hundred times.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM